136 chest CTÐØ²¿¼ÆËã»úÌå²ãÉãÓ°Êõ
137 chest roentgenogramÐØ²¿XÏßÉãÓ°Êõ
138 che
t ultrasoundÐØ²¿³¬Éù
139 Cheyne-Strokes respiration³Â£Ê©Ê½ºôÎü
140 children¶ùͯ
141 Chinese adults³ÉÄ껪ÈË
142 chronic bronchitisÂýÐÔÖ§Æø¹ÜÑ×
143 chronic cough Young Ð
ÈËÔ
144 chroni d liver diseaseÂýÐԸβ¡
145 chronic
obstructiveÂýÐÔ×èÈûÐÔ
146 ciclesonide»·Ë÷ÄεÂ
147 ciliaÏËë
148 cilomilastÎ÷Âå˾Ì
Ø
149 classification·ÖÀàh
150 clinical characteristicsÁÙ´²ÌØÕ÷
151 clinical gestaltÁÙ´²ÕûºÏÅжÏ
152 clinical outcomeÁÙ´²½á¹û
153 clinical prediction ruleÁÙ´²Ô¤²â¹æÔò
154 coagulation systemÄýѪϵͳ
155 codes of ethicsµÀµÂ±ê×¼
156 cognitive aspectsÈÏÖª¶È
157 cognitive impairmentÈÏÖªËðº¦
158 cohort studies¶ÓÁÐÑо¿
159 colony-stimulating factors ¼¯Âä´Ì¼¤Òò×Ó
160 coma»èÃÔ
161 comet-tailåçÐÇβ
162 community-acquired pneumoniaÉçÇø»ñµÃÐÔ·ÎÑ×
163 comorbiditiesºÏ²¢Ö¢
164 complianceÒÀ´ÓÐÔ
165 complications²¢·¢Ö¢
166 complications of surgeryÊÖÊõ²¢·¢Ö¢
167 computer programs¼ÆËã»ú³ÌÐò
168 concentration of NOÒ»Ñõ»¯Ì¼Å¨¶È
169 congenital heart diseaseÏÈÌìÐÔÐÄÔಡ
170 congestive heart failure³äѪÐÔÐÄÁ¦Ë¥½ß
171 connective tissue disease½áµÞ×éÖ¯¼²²¡
172 consensus statement¹²Ê¶ÉùÃ÷
173 conservative treatment±£ÊØÖÎÁÆ
174 continuous positive airway pressure³ÖÐøÆøµÀÕý
ѹ
175 control¿ØÖÆ
176 control of breathingºôÎü¿ØÖÆ
177 COPDÂýÐÔ×èÈûÐԷμ²²¡
178 cor pulmonale·ÎÔ´ÐÔÐÄÔಡ
179 coronary angioplasty¹Ú×´¶¯Âö³ÉÐÎÊõ
180 coronary artery bypass grafting¹Ú×´¶¯ÂöÅÔÂ·ÒÆ
Ö²Êõ
181 coronary artery disease¹Ú×´¶¯Âö¼²²¡
182 coronary artery stenosis¹Ú×´¶¯ÂöÏÁÕ
183 coronary artery surgery¹Ú×´¶¯ÂöÊÖÊõ
184 corticosteroidƤÖÊÀà¹Ì´¼
185 cost-effectiveness³É±¾£Ð§¹û
186 costs³É±¾
187 cough sensitivity¿ÈËÔÃô¸ÐÐÔ
188 C-reactive proteinC-·´Ó¦µ°°×
189 creatine phosphokinase¼¡ËáÁ×Ëἤø
190 critical careÖØÖ¢¼à»¤
191 critical powerÁÙ½çÄÜÁ¦
192 critically illÎ£ÖØ²¡
193 CT¼ÆËã»úÌå²ãÉãÓ°Êõ
194 CT-guided intervention¼ÆËã»úÌå²ãÉãÓ°ÊõÒýµ¼½é
195 cyclic guanosine monophosphate»·ÄñÜÕËá
196 cyclophosphamide»·Á×õ£°·
197 cystic fibrosisÄÒÐÔÏËά»¯
D
198 daily activityÈÕ³£»î¶¯
199 d-dimerd-¶þ¾ÛÌå
200 deathËÀÍö
201 decision making¾ö²ß
202 deep inspiration-induced bronchodilationÉîÎüÆø
ÓÕµ¼Ö§Æø¹ÜÀ©ÕÅ
203 deep vein thrombosisÉî¾²ÂöѪ˨ÐγÉ
204 detection¼ì²â
205 diagnosisÕï¶Ï
206 diagnostic imagingÕï¶ÏÏÔÏñ
207 diagnostic studiesÕï¶ÏÐÔÑо¿
208 diagnostic techniquesÕï¶Ï¼¼Êõ
209 diaphragmëõ¼¡
210 diastolic functionÊæÕŹ¦ÄÜ
211 diazepamµØÎ÷ãú
212 differential diagnosis¼ø±ðÕï¶Ï
213 discrimination±æ±ð
214 disease-free intervalÎÞ²¡¼äЪÆÚ
215 dissection½âÆÊ
216 docetaxel¶àÏ©×Ïɼ´¼
217 Doppler¶àÆÕÀÕ
218 Doppler echocardiography¶àÆÕÀÕ³¬ÉùÐĶ¯Í¼
219 drainageÒýÁ÷
220 drug industryÖÆÒ©ÆóÒµ
221 DuplexË«¹¦ÄÜ
222 dying´¹ËÀ
223 dynamic hyperinflation¶¯Ì¬¹ý¶È³äÆø
224 dynamic ventilatory constraint¶¯Ì¬Í¨ÆøÏÞÖÆ
225 dysphagiaÍÌÑÊÀ§ÄÑ
226 dyspneaºôÎüÀ§ÄÑ
227 dyssomnias˯ÃßÒì³£
E
228 early interventionÔçÆÚ¸ÉÔ¤
229 early peripheral lung cancersÔçÆÚÖÜΧÐͷΰ©
230 echocardiography³¬ÉùÐ͝Ãè¼ÇÊõ
231 education½ÌÓý
232 efficacyÓÐЧÐÔ
233 elderlyÀÏÄêÈË
234 electrical stimulationµç´Ì¼¤
235 electronicµç×ÓµÄ
236 emboli˨×Ó
237 emergency department¼±Õï¿Æ
238 emission-CT·¢ÉäÐͼÆËã»úÌå²ãÉãÓ°Êõ
239 endarterectomy¶¯ÂöÄÚĤÇгýÊõ
240 endobronchial ultrasonographyÖ§Æø¹ÜÄÚ³¬Éù
241 endobronchial valveÖ§Æø¹ÜÄÚ»î°ê
242 end-of-life careÁÙÖչػ³
243 endothelial dysfunctionÄÚÆ¤¹¦ÄÜÕϰ
244 endothelial functionÄÚÆ¤¹¦ÄÜ
245 endotoxinÄÚ¶¾ËØ
246 endotracheal intubationÆø¹ÜÄÚ²å¹Ü
247 end-tidal³±ÆøÄ©
248 enzyme-linked immunosorbent assayøÁªÃâÒßÎü
¸½ÊÔÑé
249 eosinophilicÊÈËáÐÔ
250 eosinophilsÊÈËáϸ°û
251 eotaxin-3ÊÈËáÐÔÁ£Ï¸°ûÇ÷»¯Òò×Ó-3
252 epidemiologyÁ÷Ðв¡Ñ§
253 epidermal growth factor±íƤÉú³¤Òò×Ó
254 epidermal growth factor receptor±íƤÉú³¤Òò×ÓÊÜ
Ìå
255 epithelial cellsÉÏÆ¤Ï¸°û
256 2-[18F]fluoro-2-deoxy-D-glucose positron emission to-
mography2-[18F]·ú-2-ÍÑÑõ-D-ÆÏÌÑÌÇ (FDG)
Õýµç×Ó·¢ÉäÌå²ãÉãÓ°Êõ
257 erythropoietin´Ùºìϸ°ûÉú³ÉËØ
258 ethaneÒÒÍé
259 ethane in exhaled breathºô³öÆøÒÒÍé
260 ethnicityÈËÖÖѧ
261 etiology²¡Òòѧ
262 exacerbations¼±ÐÔ¼ÓÖØ
263 exerciseÔ˶¯
264 exercise capacityÔ˶¯ÄÜÁ¦
265 exercise testingÔ˶¯ÊÔÑé
266 exercise therapyÔ˶¯ÖÎÁÆ
267 exercise toleranceÔ˶¯ÄÍÁ¿
268 exercise trainingÔ˶¯ÑµÁ·
269 exercise-inducedÔ˶¯ÓÕ·¢
270 exercise-induced asthmaÔ˶¯ÓÕ·¢Ïø´
271 exhaled breath condensateºô³öÆøÀäÄýÒº
272 extrapulmonary tuberculosis·ÎÍâ½áºË
273 extravascular lung waterѪ¹ÜÍâ·ÎË®
274 extravascular lung water indexѪ¹ÜÍâ·ÎˮָÊý
275 extubation failure°Î¹Üʧ°Ü
276 exudatesÉø³öÒº
F
277 fat embolismÖ¬·¾Ë¨Èû
278 fellowship trainingÃâ·ÑÅàѵ
279 femaleÅ®ÐÔ
280 FEV1µÚ1ÃëÓÃÁ¦ºôÆøÁ¿
281 flow-mediated vasodilationѪÁ÷½éµ¼ÐÔѪ¹ÜÀ©ÕÅ
282 flowmetersÁ÷Á¿¼Æ
283 fluorodeoxyglucose·úÍÑÑõÆÏÌÑÌÇ
284 fluoroquinolones·úàŵͪÀà
285 fluorothymidine·úÐØÜÕ
286 follow-upËæ·Ã
287 follow-up studiesËæ·ÃÑо¿
288 forced expiratory volume in 3 sµÚ3ÃëÓÃÁ¦ºôÆøÁ¿
289 forced oscillation techniqueÓÃÁ¦Õñµ´¼¼Êõ
290 formoterol¸£ÄªÌØÂÞ
291 fractional flow reserveѪÁ÷´¢±¸·ÖÊý
292 FVCÓÃÁ¦·Î»îÁ¿
G
293 gastroesophageal refluxθʳ¹Ü·´Á÷
294 gemcitabine¼ªÎ÷Ëû±õ
295 gender differencesÐÔ±ð²îÒì
296 gene-environmental interactionÒÅ´«£»·¾³µÄÏ໥
×÷ÓÃ
297 general practiceÈ«¿ÆÒ½Ñ§
298 genetic predispositionÒÅ´«ËØÖÊ
299 genetic predisposition to disease¼²²¡Ò׸ÐÐÔ»ùÒò
300 geographyµØÀí
301 geriatric assessmentÀÏÄêÈËÉíÐĽ¡¿µÆÀ¼Û
302 Ghrelin¼¢¶ñ¼¤ËØ
303 glottic-stop reflexÉùÃűպϷ´Éä
304 glucocorticoidÌÇÆ¤Öʼ¤ËØÀà
305 glucocorticosteroid treatmentÌÇÆ¤ÖÊÀà¹Ì´¼¼¤ËØ
ÖÎÁÆ
306 glucoseÆÏÌÑÌÇ
307 glutathione S-transferase M1¹Èë׸ÊëÄS×ªÒÆÃ¸
M1
308 glutathione S-transferase P1 gene¹Èë׸ÊëÄS×ªÒÆ
øP1»ùÒò
309 goal-directed volume therapyÄ¿±êµ¼ÏòÐÔÈÝÁ¿ÖÎÁÆ
310 goodness-of-fit testÄâºÏÓŶȼìÑé
311 granulocyte macrophage colony-stimulating factor
Á£Ï¸°û¾ÞÊÉϸ°û¼¯Âä´Ì¼¤Òò×Ó
312 granulomaÈâÑ¿Ö×
313 gravityÖØÁ¦
314 guidelinesÖ¸ÄÏ
H
315 Haemophilus influenzaeÁ÷¸ÐÊÈѪ¸Ë¾ú
316 hand-carried ultrasoundÊÖЯʽ³¬Éù
317 haplotypeµ¥±¶ÐÍ
318 hay fever»¨·ÛÈÈ
319 hazard ratio·çÏÕ±È
320 health½¡¿µ
321 health careÎÀÉú±£½¡
322 health services researchÎÀÉú·þÎñÑо¿
323 health status indicators½¡¿µ×´¿öÖ¸±ê
324 health technology assessmentÎÀÉú¼¼ÊõÆÀ¹À
325 health-related quality of life½¡¿µÏà¹ØÉú»îÖÊÁ¿
326 heart diseaseÐÄÔಡ
327 heart failureÐÄÁ¦Ë¥½ß
328 heart rateÐÄÂÊ
329 heartburnÎ¸×ÆÈÈ
330 heliumº¤Æø
331 helmetÍ·¿ø
332 hematocritѪϸ°û±ÈÈÝ
333 hematopoietic stem-cell transplantÔìѪ¸Éϸ°ûÒÆÖ²
334 heme oxygenaseѪºìËØ¼ÓÑõø
335 hemoptysis¿©Ñª
336 hemorrhage³öѪ
337 hemostatic therapyֹѪÖÎÁÆ
338 high dose´ó¼ÁÁ¿
339 high-altitude pulmonary edema¸ßÔÐÔ·ÎË®Ö×
340 high-resolution¸ß·Ö±æ
341 histology×é֯ѧ
342 histopathologic classification×éÖ¯²¡Àíѧ·ÖÀà
343 home exposure¼ÒÍ¥±©Â¶
344 home mechanical ventilation¼ÒÍ¥»úÐµÍ¨Æø
345 homelessÁ÷ÀË
346 homocysteineͬÐͰëë×°±Ëá
347 hospital mortalityסԺ²¡ËÀÂÊ
348 hospital volumeÒ½Ôº¹æÄ£
349 human herpesvirus-8ÈËÀàðåÕ¶¾-8
350 human studyÈËÀàÑо¿
351 hypercapnia¸ß̼ËáѪ֢
352 hypercapnic encephalopathy¸ß̼ËáÄÔ²¡
353 hypercholesterolemia¸ßµ¨¹Ì´¼ÑªÖ¢
354 hyperCKemia¸ß¼¡ËáÁ×ËἤøѪ֢
355 hyperinflation¹ý¶È³äÆø
356 hyperosmolality¸ßÉøÐÔ
357 hypersecretion¸ß·ÖÃÚ
358 hypersensitivity³¬Ãô·´Ó¦
359 hypertension¸ßѪѹ
360 hyperthermia·¢ÈÈ
361 hypothalamo-hypophyseal systemÏÂÇðÄÔ£´¹Ìå
ϵͳ
362 hypothermiaµÍÎÂ
363 hypovolemiaµÍѪÈÝÁ¿
364 hypoxemiaµÍÑõѪ֢
I
365 ICUÖØÖ¢¼à»¤²¡·¿
366 ICU risk stratification scoreICUΣÏÕ·Ö²ãÆÀ·Ö
367 idiopathic pulmonary arterial hypertensionÔ·¢
ÐԷζ¯Âö¸ßѹ
368 immediate hypersensitivity³¬Ãô·´Ó¦£¬ËÙ·¢ÐÍ
369 immune modulationÃâÒßµ÷½Ú
370 immune responsivenessÃâÒß·´Ó¦
371 immunosuppressionÃâÒßÒÖÖÆ
372 incidence·¢²¡ÂÊ
373 induced sputumÓÕµ¼Ìµ
374 inducible nitric oxide synthaseÓÕµ¼ÐÍÒ»Ñõ»¯µªºÏ
ø
375 inductive plethysmographyµç¸ÐÓ¦Ìå»ýÃè¼ÇÊõ
376 infantÓ¤¶ù
377 infection¸ÐȾ
378 infection-free intervalÎÞ¸ÐȾ¼äЪÆÚ
379 infectivity´«È¾ÐÔ
380 inflammationÑ×Ö¢
381 information systemsÐÅϢϵͳ
382 inhalationÎüÈë
383 inhalation injuryÎüÈëÐÔËðÉË
384 inhaled corticosteroidsÎüÈëÆ¤ÖÊÀà¹Ì´¼¼¤ËØ
385 insomniaʧÃß
386 inspiratory capacityÉîÎüÆøÁ¿
387 inspiratory muscle trainingÎüÆø¼¡ÑµÁ·
388 integrinsÕûºÏËØ
389 interdisciplinary intervention¶àѧ¿Æ¸ÉÔ¤
390 interference¸ÉÈÅ
391 interferon¸ÉÈÅËØ
392 interferon-g¸ÉÈÅËØ-g
393 interleukin-10°×ϸ°û½éËØ-10
394 interleukin-5°×ϸ°û½éËØ-5
395 interleukin-8°×ϸ°û½éËØ-8
396 internal thoracic arteryÈéÄÚ¶¯Âö
397 interstitial lung disease¼äÖÊÐԷβ¡
398 intervention¸ÉÔ¤
399 interventional procedures½éÈëÖÎÁÆ
400 interventional pulmonology½éÈë·ÎÔಡѧ
401 intrathoracic blood volumeÐØÄÚѪÈÝÁ¿
402 intrathoracic blood volume indexÐØÄÚѪÈÝÁ¿Ö¸Êý
403 intrathoracic lymphadenopathyÐØÇ»ÄÚÁܰͽᲡ±ä
404 intravascular tumorѪ¹ÜÄÚÖ×Áö
405 invasive mechanical ventilationÓд´»úÐµÍ¨Æø
406 invasive pulmonary aspergillosisÇÖÏ®ÐÔ·ÎÇúù¾ú²¡
407 investigationµ÷²é
408 ipratropium bromide nasal sprayÒì±ûÍÐäåï§Åç±Ç
409 ironÌú
410 ischemiaȱѪ
411 ischemia-reperfusion injuryȱѪ£ÔÙ¹à×¢ËðÉË
412 ischemic strokeȱѪÐÔ×äÖÐ
413 isolated perfused heart·ÖÀëµÄÔÙ¹à×¢ÐÄÔà
K
414 Kaposi sarcoma-associated herpesvirus¿¨²¨Î÷Èâ
ÁöÏà¹ØðåÕ¶¾
415 KITÊÔ¼ÁºÐ
416 Koreaº«¹ú
L
417 laboratoryʵÑéÊÒ
418 lactic acidosisÈéËáËáÖж¾
419 latex-enhanced immunoassayÈ齺ÔöÇ¿ÃâÒ߲ⶨ
420 left atrial appendage×óÐĶú
421 left ventricle×óÐÄÊÒ
422 Legionella¾üÍžú
423 Legionnaires disease¾üÍžú²¡
424 length of stayסԺʱ¼ä
425 less invasive surgery΢´´ÐÔÊÖÊõ
426 leukocyte elastase°×ϸ°ûµ¯ÐÔµ°°×ø
427 leukotriene receptor antagonist°×ÈýÏ©ÊÜÌåÞ׿¹¼Á
428 levalbuterol×óÐýɳ¶¡°·´¼
429 levofloxacin×óÑõ·úɳÐÇ
430 lidocaineÀû¶à¿¨Òò
431 lifestyleÉú»î·½Ê½
432 limited resection¾Ö²¿Çгý
433 lipopolysaccharideÖ¬¶àÌÇ
434 6-min walking test6·ÖÖÓ²½ÐÐÊÔÑé
435 liver¸ÎÔà
436 lobectomyÒ¶Çгý
437 long-acting anticholinergic³¤Ð§¿¹µ¨¼îÄÜÒ©
438 long-acting ¦Â2-agonist³¤Ð§b2-ÊÜÌ弤¶¯¼Á
439 longitudinal study×ÝÏòÑо¿
440 long-term clinical remission³¤ÆÚÁÙ´²»º½â
441 long-term oxygen therapy³¤ÆÚÑõÁÆ
442 lorazepamÀÍÀÎ÷ãú
443 low-molecular-weight heparinµÍ·Ö×Ó¸ÎËØ
444 lung abscess·ÎŧÖ×
445 lung attenuation·ÎË¥¼õ
446 lung cancer·Î°©
447 lung cancer diagnosis and staging·Î°©Õï¶ÏºÍ·ÖÆÚ
448 lung cancer surgery·Î°©ÊÖÊõ
449 lung diffusion·ÎÃÖÉ¢
450 lung diseases·Î²¿¼²²¡
451 lung elastic recoil·Îµ¯ÐÔ»ØËõÁ¦
452 lung function·Î¹¦ÄÜ
453 lung metastasis·Î×ªÒÆ
r2006Äê¹Ø¼ü´Ê×Ü»ã Girl Girl Young Girl RSS 12y g Seductive Young Seductive q2006Äê¹Ø¼ü´Ê×Ü»ã Girl Girl Young Girl RSS 12c i i Seductive Girl